Ampio Pharmaceuticals (NYSE:AMPE) Coverage Initiated by Analysts at StockNews.com

StockNews.com began coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a research report report published on Sunday. The firm issued a sell rating on the stock.

Ampio Pharmaceuticals Stock Performance

Shares of NYSE AMPE opened at $0.00 on Friday. The firm has a market cap of $570.00, a P/E ratio of 0.00 and a beta of 3.71. Ampio Pharmaceuticals has a 1-year low of $0.00 and a 1-year high of $2.47. The business’s 50 day moving average is $0.02 and its 200-day moving average is $0.01.

About Ampio Pharmaceuticals

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.